LPL Financial
CRBP icon

LPL Financial’s Corbus Pharmaceuticals CRBP Stock Holding History

LPL Financial’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,116
Closed -$17K – 4503
2022
Q4 		$17K Hold
5,116
– – ﹤0.01% 4381
2022
Q3 		$25K Buy
5,116
+800
+19% +$5.64K ﹤0.01% 4302
2022
Q2 		$33K Buy
4,316
+22
+0.5% +$213 ﹤0.01% 4284
2022
Q1 		$68K Sell
4,294
-88
-2% -$1.17K ﹤0.01% 4023
2021
Q4 		$81K Buy
4,382
+235
+6% +$6.37K ﹤0.01% 4169
2021
Q3 		$127K Buy
4,147
+1,580
+62% +$62.3K ﹤0.01% 4089
2021
Q2 		$141K Buy
2,567
+91
+4% +$5.05K ﹤0.01% 3987
2021
Q1 		$146K Buy
2,476
+1,282
+107% +$84.3K ﹤0.01% 3859
2020
Q4 		$45K Buy
1,194
+741
+164% +$27.7K ﹤0.01% 3735
2020
Q3 		$24K Buy
453
+81
+22% +$14.7K ﹤0.01% 3492
2020
Q2 		$94K Buy
+372
New +$75.2K ﹤0.01% 3298
2019
Q2 		– Sell
-475
Closed -$99K – 3293
2019
Q1 		$99K Buy
+475
New +$105K ﹤0.01% 3071
2016
Q2 		– Sell
-467
Closed -$27K – 2683
2016
Q1 		$27K Buy
+467
New +$20.6K ﹤0.01% 3042

Other funds holding CRBP

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

LPL Financial's CRBP Position: Q1 2023 in Review

LPL Financial sold out of Corbus Pharmaceuticals (CRBP) in Q1 2023, closing a stake of 5,116 shares — an estimated $17K sold.

LPL Financial first reported a position in CRBP in Q1 2016 and held it in 13 quarters. The position peaked at $146K in Q1 2021. 30 funds tracked by Wall St. Rank hold CRBP as of Q1 2023.

  • LPL Financial reported no remaining Corbus Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • LPL Financial sold 5,116 Corbus Pharmaceuticals shares in Q1 2023, an estimated $17K.
  • LPL Financial first reported a position in Corbus Pharmaceuticals in Q1 2016 and held it in 13 quarters.
  • LPL Financial's Corbus Pharmaceuticals position peaked at $146K in Q1 2021.
  • 30 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2023.

Based on LPL Financial's 13F filing for Q1 2023, filed 10 May 2023.